Long-term branched-chain amino acid supplementation improves glucose tolerance in patients with nonalcoholic steatohepatitis-related cirrhosis

Internal Medicine

Volumn 51, Issue 16, 2012, Pages 2151-2155

  Miyake, Teruki ^a   Abe, Masanori ^a   Furukawa, Shinya ^a   Tokumoto, Yoshio ^a   Toshimitsu, Kumiko ^b   Ueda, Teruhisa ^a   Yamamoto, Shin ^a   Hirooka, Masashi ^a   Kumagi, Teru ^a   Hiasa, Yoichi ^a   Matsuura, Bunzo ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Branched chain amino acid; Cirrhosis; Glycemic control; Nonalcoholic steatohepatitis

Indexed keywords

ALBUMIN; BRANCHED CHAIN AMINO ACID; C PEPTIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; ASCITES; BODY WEIGHT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIET THERAPY; DRUG DOSE REDUCTION; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; MALLORY BODY; NONALCOHOLIC FATTY LIVER; PROTEIN INTAKE; SPLENOMEGALY; SUPPLEMENTATION;

AGED; AMINO ACIDS, BRANCHED-CHAIN; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FATTY LIVER; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LAPAROSCOPY; LIVER CIRRHOSIS; MIDDLE AGED;

EID: 84865110913     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7578     Document Type: Article

References (20)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcohlic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438, 1980.
2. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121, 2005.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
5. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
6. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850, 2001.
7. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35: 367-372, 2002.
8. Nakaya Y, Okita K, Suzuki K, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 23: 113-120, 2007.
9. Marchesini G, Bianchi G, Merli M, et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double blind, randomized trial. Gastroenterology 124: 1792-1801, 2003.
10. Muto Y, Sato S, Watanabe A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3: 705-713, 2005.
11. Kawaguchi T, Taniguchi E, Itou M, et al. Branched-chain amino acids improve insulin resistance in patients with hepatitis C virusrelated liver disease: report of two cases. Liver Int 27: 1287-1292, 2007.
12. Urata Y, Okita K, Korenaga K, Uchida K, Yamasaki T, Sakaida I. The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis. Hepatol Res 37: 510-516, 2007.
13. Plauth M, Cabré E, Riggio O, et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 25: 285-294, 2006.
14. Flegal KM, Ogden CL, Wei R, Kuczmarski RL, Johnson CL. Prevalence of overweight in US children: comparison of US growth charts from the Centers for Disease Control and Prevention with other reference values for body mass index. Am J Clin Nutr 73: 1086-1093, 2001.
15. Silverman JF, Pories WJ, Caro JF. Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu 24 (Pt 1): 275-302, 1989.
16. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 20: 119-125, 1994.
17. Petrides AS, DeFronzo RA. Glucose and insulin metabolism in cirrhosis. J Hepatol 8: 107-114, 1989.
18. Imano E, Kanda T, Nakatani Y, et al. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol 31: 469-473, 1999.
19. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun 299: 693-696, 2002.
20. Nishitani S, Takehana K. Pharmacological activities of branchedchain amino acids: augmentation of albumin synthesis in liver and improvement of glucose metabolism in skeletal muscle. Hepatol Res 30S: 19-24, 2004.